iShares Genomics Immunology and Healthcare ETF (IDNA)
$40.96+1.04%Close
Snapshot
- 1 week
- -1.4%0.0% vs SPY
- 1 month
- +2.8%+2.2% vs SPY
- Assets
- $192.1M
- Expense ratio
- 0.47%
- Fund type
- EQUITY
- Distribution yield
- 0.69%
- Dividend growth
- +6.4%
Signal: Call, Regime, Alignment, Score, ATR trend, HiLo flip, Coil, Exhaustion, Topping · Technicals (EMA stack, slope, squeeze, stochastic, MACD-Z, DI+) · Price & returns: 3 months, Year to date, 1 year · Fund: Income score, Valuation
Price & returns: 3 years, 5 years
Signal: Composite · Performance (Q-Score, Sharpe, Sortino, Calmar, CAGR, drawdown, alpha)
Signal evidence
Best Combo (today's action, held-out profit factor and family votes) · White Arrow (the call, its profit factor and closed trades) · Regime (today's regime and the regime model's profit factor) · Exhaustion (whether buyers or sellers are stretched today and the latest release)
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Fund
About
iShares Genomics Immunology and Healthcare ETF (IDNA). The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
SEC filingsCIK 1100663
